Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

DICE DICE THERAPEUTICS, INC.

20.280
+0.630+3.21%
Close 09/30 16:00 ET
20.2800.0000.00%
Post Mkt Price 09/30 16:02 ET
High
20.720
Open
19.560
Turnover
7.37M
Low
19.490
Pre Close
19.650
Volume
363.94K
Market Cap
774.92M
P/E(TTM)
Loss
52wk High
38.180
Shares
38.21M
P/E(Static)
Loss
52wk Low
12.635
Float Cap
506.68M
Bid/Ask %
33.33%
Historical High
40.499
Shs Float
24.98M
Volume Ratio
0.85
Historical Low
12.635
Dividend TTM
--
Div Yield TTM
--
P/B
2.79
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.46%
Amplitude
6.26%
Avg Price
20.260
Lot Size
1
Float Cap
506.68M
Bid/Ask %
33.33%
Historical High
40.499
Shs Float
24.98M
Volume Ratio
0.85
Historical Low
12.635
Dividend TTM
--
P/B
2.79
Dividend LFY
--
Turnover Ratio
1.46%
Amplitude
6.26%
Avg Price
20.260
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Dice Molecules Holdings LLC is a biopharmaceutical company. It designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA.
CEO: Dr. J. Kevin Judice, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...